Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (1)	6/7/2000 8:39:00 AM
From: scott_jiminez	Respond to of 278

Simply fascinating. A quote from the BW cover story (the genuflect-to-Venter issue) , Through most of the 1990s, drugmakers had hoped that when they discovered a gene that causes a disease, they could use knowledge of that gene to devise a new drug. ''It was the wrong promise. It oversold and stifled the development of the whole industry,'' says Novartis' Polymeropolous, who discovered the gene that causes Parkinson's disease. ''Now we know that the gene that causes a disease is actually irrelevant as a drug target.'' The gene that causes Parkinson's disease? Fascinating. Too bad no one else has been informed of this (probably because it hasn't happened...but that's 'irrelevant'). And targeting a gene that causes a disease is 'actually irrelevant'? At least the guy is consistent with the credibility of his statements...